BackPhoenix Biotech Acquisition Overview

Phoenix Biotech Acquisition Goodwill

Phoenix Biotech Acquisition's goodwill is $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Phoenix Biotech Acquisition Goodwill History

Loading

Phoenix Biotech Acquisition vs. peers: Goodwill Comparison

Loading

Phoenix Biotech Acquisition Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Phoenix Biotech Acquisition (PBAX) FAQ

The latest goodwill for PBAX is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Phoenix Biotech Acquisition's historical trend and sector peers before judging valuation or financial health.

Over the past year, PBAX's goodwill moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Phoenix Biotech Acquisition's operating scale or balance-sheet position.

A goodwill figure of $0 for PBAX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PBAX's goodwill ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.